Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity. Wenqiang Shi et al.
Published: 2 April 2024| Version 1 | DOI: 10.17632/7k6wwcy568.1
Contributor:
Huili LuDescription
Figure S2D: Reducing SDS-PAGE analysis of anti-PD-L1, LH03 or LH05 as well as uPA-cleaved LH03 or LH05. Figure 7C: Immunohistochemical staining for Ki67 was performed on the tumor tissues to assess cell proliferation. Figure 7E: Immunofluorescence staining for CD8 (green) and Foxp3 (red) was performed on the tumor tissues. Figure S7A: Reducing SDS-PAGE analysis of LH06 as well as MMP-cleaved LH06.
Files
Institutions
Shanghai Jiao Tong University
Categories
Bioengineering, Cytokine Immunotherapy